Fusion Antibodies PLC Strategic Asset Allocation Index
Fusion Antibodies PLC strategic asset allocation index. Fusion Antibodies PLC (FAB) has a Strategic Asset Allocation Index of 33.4% as of March 2023. Strategic assets (PP&E of GBX375.00K plus long-term investments of GBX-) total GBX375.00K, measured against net assets of GBX1.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Fusion Antibodies PLC net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Fusion Antibodies PLC (2006–2023)
Strategic asset allocation index of Fusion Antibodies PLC from 2006 to 2023. This chart shows how Fusion Antibodies PLC's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2023. As of March 2023, the index stands at 33.4%, representing strategic assets of GBX375.00K against net assets of GBX1.12 Million GBX. Check FAB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Fusion Antibodies PLC Strategic Asset Allocation Index by Year (2006–2023)
Fusion Antibodies PLC strategic asset allocation index by year from 2006 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Fusion Antibodies PLC from 2006 to 2023, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Fusion Antibodies PLC.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 33.4% | GBX375.00K | GBX375.00K | GBX- | GBX1.12 Million | ▲ +16.2 pp |
| 2022 | 17.2% | GBX633.00K | GBX633.00K | GBX- | GBX3.68 Million | ▼ -6.5 pp |
| 2021 | 23.7% | GBX1.12 Million | GBX1.12 Million | GBX- | GBX4.75 Million | ▼ -6.9 pp |
| 2020 | 30.5% | GBX1.47 Million | GBX1.47 Million | GBX- | GBX4.81 Million | ▲ +0.9 pp |
| 2019 | 29.7% | GBX1.59 Million | GBX1.59 Million | GBX- | GBX5.35 Million | ▲ +21.3 pp |
| 2018 | 8.3% | GBX546.73K | GBX546.73K | GBX- | GBX6.58 Million | ▲ +2.0 pp |
| 2017 | 6.3% | GBX107.25K | GBX107.25K | GBX- | GBX1.71 Million | ▲ +2.9 pp |
| 2016 | 3.4% | GBX49.97K | GBX49.97K | GBX- | GBX1.46 Million | ▼ -270.4 pp |
| 2014 | 273.8% | GBX44.68K | GBX44.68K | GBX- | GBX16.32K | ▲ +164.1 pp |
| 2013 | 109.7% | GBX55.00K | GBX55.00K | GBX- | GBX50.13K | ▲ +66.1 pp |
| 2011 | 43.7% | GBX141.00K | GBX141.00K | GBX- | GBX323.00K | ▼ -5.8 pp |
| 2010 | 49.4% | GBX254.00K | GBX254.00K | GBX- | GBX514.00K | ▼ -116.5 pp |
| 2009 | 166.0% | GBX312.00K | GBX312.00K | GBX- | GBX188.00K | ▲ +115.1 pp |
| 2008 | 50.8% | GBX333.00K | GBX333.00K | GBX- | GBX655.00K | ▼ -16.6 pp |
| 2007 | 67.4% | GBX410.00K | GBX410.00K | GBX- | GBX608.00K | ▲ +13.5 pp |
| 2006 | 53.9% | GBX110.00K | GBX110.00K | GBX- | GBX204.00K | — |